Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Identify passive funds with low turnover to improve tax efficiency and stability. Compare options and select high-quality, low-turnover strategies.
27,282 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
A top tech stock faces a likely pullback in the second half of 2026 as demand shifts and costs rise. Traders should h...
Salesforce stock today has been in the spotlight as investors weigh new AI advancements against business execution. T...
Oil prices rise and equity futures turn lower as tensions with Iran fresh escalate. Investors brace for higher energy...
Aehr Test Systems stock surged after a positive AI-fueled forecast. This article breaks down the catalysts, the risks...
Vale’s shares fell as iron ore demand in China cooled, signaling wider margin pressures for metals. This guide breaks...
ANI Pharma's Q4 2025 results set the stage for the pharma space. This guide breaks down what the numbers mean for the...
The crypto market has questions about XRP at sub-$1.50 levels. This guide weighs the risks and potential rewards, off...
Bitcoin has fallen about 19% this year, prompting a closer look at three ETF types—spot, futures, and leveraged futur...
Real Brokerage deepens its Kansas City presence by adding Chartwell Realty, bringing 150 agents and cementing its sta...
A large stake exit sent shockwaves through a payments stock, pulling it down by about half from its highs. This artic...
Volatility is shaping a smarter approach to investing. Discover three growth stocks worth $5,000 and how to build a f...